Abstract

To reduce breast tumor size before surgery, neoadjuvant chemotherapy is applied systematically to patients with local breast cancer. However, with the current protocols, it is not yet workable to have an early prediction on the effect of chemotherapy on a patient. Predicting response to chemotherapy could reduce toxicity and delays to effective treatment. Computational analysis of dynamic contrast-enhanced magnetic resonance images (DCE-MRI) through deep convolution neural network (CNN) has proved a significant performance to classify responsive and nonresponsive patients. This presents a new explainable deep learning (DL) model for predicting breast cancer response to chemotherapy based on multiple MRI inputs.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.